Paxil
Prinivil
Xenical
Ampicillin
Actos
I find that live green-leafy vegetables are quite beneficial. Oic acid will appear in the future as a key component of practically all drug formulations at amounts corresponding to a contribution of oxidative stress to ethiopathogenesis of a given disease. At present, not only the role of ROS in pathomechanism of many diseases, for example, actos lascivos. Thank you. Our final question comes from Abe in Connecticut. Please state your question. Yes. This would be primarily for Dr. Richardson. Would it be possible to mitigate the effect of amyloid doses, which remains sometime after treatment is ceased? It is a real problem in the articulation, as you may hear, as well as in eating. Yes, thank you for the question on that. I obviously very sorry to hear that you're still dealing with the consequences of the amyloid. It's one of the biggest challenges I've found in patients who have developed systemic symptoms from amyloid doses, that many of the symptoms they encounter are not necessarily easily reversible, even though some of the treatment that they receive can be effective. I have to say my experience with amyloid-related neuropathy is quite limited. But I would say that it's something where we certainly try the supplements, but with only modest success to date. I think the challenge of trying to remove or reverse the damage that the amyloid causes, once it has occurred, is a big one. I would suggest, especially for swallowing and these other issues that you're reporting, what has probably been I think most useful in the groups we work with, especially across town and here in Boston, we work with a very super group at BU [Boston University] Medical Center, led by Vaishali Sanchorawala and her colleagues who have a special interest in amyloid doses. They have an ENT [ear, nose, and throat] team who work with them who help with the symptom management of swallowing and so forth. Probably a liaison with a center that has a specific ENT group who are interested in this is a good way to go. Retinoic acid causes disruption of the seminiferous cords in the testis of rat fetuses Marinos et al., 1995; Cupp et al., 1999; Livera et al., 2000 ; Fig. 2 ; and also has numerous other effects on testicular development Table 2 ; . Cupp et al. 1999 ; showed that retinoids increased transcription of the three isoforms of transforming growth factor TGF- ; in cultured neonatal testicular cells. Our group used an organotypic culture system to show that retinoic acid inhibits the stimulatory effect of FSH on the production of cAMP in rat Sertoli cells during fetal and neonatal life. The use of selective synthetic analogues of the different RAR and RXR revealed that this effect involves RAR- Livera et al., 2001 ; . Furthermore, after birth, retinoic acid increases the proliferation of Sertoli cells via RAR- Livera et al., 2001 ; as well as their production of transferrin G. Livera, unpublished ; . Retinoic acid diminishes the proliferation of fetal and neonatal gonocytes by acting on both apoptosis and mitosis via the activation of RAR- Boulogne et al., 1999; Livera et al., 2000, 2001; B. Boulogne, unpublished ; . The knockout of RAR- led to an increase in the number of germ cells in mouse fetuses and neonates, indicating the involve, because actos prescription.

Actos 15mg pioglitazone

J pharmacol, 198 16 suppl 3 ; : 1-1 1 al-zuhair, h. Tab might be appropriate lab for cautiously chosen individuals derives at considerable medical partridge risk because of the individuals too ` fatness hose and adalat. How to order contact us shopping cart generic vs brand product list acne products retin-a allergy allegra loratadine zyrtec view all 4 products singulair anabolic steroid nuberol antibacterial cipro anticoagulants coumadin anticonvulsant lamictal view all 2 products neurontin antidepressant zyban paxil view all 6 products effexor xr pamelor prozac zoloft antifungal lamisil arthritis arava asthma allegra loratadine zyrtec view all 4 products singulair blood pressure adalat coreg norvasc altace cozaar verapamil view all 15 products avapro cardura lasix lopressor lotensin monopril prinivil tenormin vasotec cancer nolvadex cardiovascular adalat coreg tiazac view all 6 products digiter plavix tenormin cholesterol lipitor tricor zocor view all 5 products mevacor pravachol diabetes actos amaryl glucophage view all 5 products avandia glucotrol xl hair loss propecia lifestyle cialis cialis soft tabs levitra viagra viagra soft tabs flomax - men's health cialis cialis soft tabs levitra propecia viagra viagra soft tabs flomax mental health seroquel paxil view all 3 products zoloft osteoporosis fosamax pain medications soma ultram view all 3 products celebrex skin care lamisil stomach zantac nexium prilosec view all 5 products prevacid protonix stop smoking zyban thyroid synthroid weight loss meridia view all 2 products phentermine woman's health evista fosamax imitrex nolvadex view all 5 products clomid alphabetical list: a b c generic cipro - ciproloxacin generic cipro ciproloxacin 500mg shape and color of the pill may differ from the image!
In clinical trials, over 4700 patients have received actos , over 3300 patients have been treated for 6 months or longer, and over 450 patients for one year or longer and adderall. Pital in Bangkok, Vijay Batra peered through a microscope at a drop of blood from a malaria patient. Focusing on a cluster of red blood cells, Batra, chief of development for Ranbaxy Laboratories, India's largest drug company, saw almost no malaria parasites where 48 hours earlier there had been hordes of them. The microscopic massacre had been caused by a. Utilization Management Staff VBH-PA places a high value on the selection, training and performance evaluation of clinical staff performing utilization management services. All staff involved in utilization management activities possess terminal degrees and licensure in their field. VBH-PA Physician Peer Advisors and Medical Directors are experienced, senior level clinicians, many of whom remain active in private practice. They are board certified in their specialty areas and are required to maintain a current knowledge of behavioral health research findings and nationally recognized practice guidelines. Licensed Clinical Psychologists provide peer reviews for psychological testing and outpatient treatment. The clinical Utilization Management staff is multidisciplinary and is able to manage care in all general psychiatric, psychiatric subspecialty and substance abuse areas. VBH-PA requires that all of our Service Managers and reviewers be fully licensed mental health professionals with a minimum of three years prior clinical experience in a mental health substance abuse setting providing direct patient care. First-level review staff may be nurses RN or MSN ; or masters, doctoral prepared licensed behavioral health clinicians. These reviewers complete all types of reviews, including referral, precertification, concurrent review, discharge planning and complex care management. All providers are required to comply with the review process and albuterol.
The United States Pharmacopeia "Thyroid is the cleaned, dried, and powdered thyroid gland previously deprived of connective tissue and fat. It is obtained from domesticated animals that are used for food by humans." "On hydrolysis it yields not less than 90.0 percent and not more than 110.0 percent of each of the labeled amounts of Levothyroxine C15H11I4NO4 ; and Liothyronine C15H12I3NO4 ; , calculated on the dried basis. It is free from iodine in inorganic or any form of combination other than that peculiar to the thyroid gland. It may contain a suitable diluent such as Lactose, Sodium Chloride, Starch, Sucrose, or Dextrose." DESCRIPTION: "Thyroid occurs as a light-tan to medium-tan colored, amorphous powder, having a slight, characteristic, meat-like odor and a saline taste." HOW SUPPLIED: Packaging: Bulk, polylined and sealed fiber drums. Potencies: THYROID USP THYROID 3 X USP THYROID FULL STRENGTH.

TABLE 1. Responses of E. coli to three categories of quinolone and alesse.

Actos escolares 20 de junio

The survey was not commissioned to establish a database. The company already had a customer database, which contained names, addresses, and therapeutic specialty for health professionals, and complied with all applicable privacy laws. The personal data provided would be cross referenced against and integrated into its internal database and used to invite health professionals to attend conferences and to participate in other programmes, to deliver educational materials as well as other products and services, including promotional activities that might be of interest. This complied with the requirements of Clause 10.2 of the Code. In terms of the market research approach undertaken and how the information provided would be used to ensure compliance with the Code and the BHBIA framework the following standards were applied: The research was conducted through a reputable market research agency. The agency was a member of BHBIA, the European Pharmaceutical Marketing Research Association EphMRA ; and the Pharmaceutical Business Intelligence and Research Group PBIRG ; and, as such, was bound by the `The Legal and Ethical Framework for Healthcare Market Research', as referred to in Clause 10.2 of the Code. The agency concerned understood that this research complied with the Code. The survey was designed to comply with the core principles of the BHBIA Framework. Participants were honestly and comprehensively informed about the research in which they were taking part. The covering letter explicitly stated the purpose of the research and how the information was intended to be used, ensuring full transparency. No attempt was made to disguise the nature of the study. The survey clearly stated the research was being commissioned by Merck Sharp and Dohme as required by the Code; there was no implication that the survey was independent from the company. The survey explicitly outlined how the personal data provided would be used, and aimed to address this up-front, to ensure the respondent was not misled in anyway. In compliance with the BHBIA framework informed consent was also required in order for the information provided by participants to be processed and was not and would not be accessible to Merck Sharp & Dohme if not completed correctly. Merck Sharp & Dohme had tried to provide participants with sufficient relevant information to enable them to make an informed judgement about whether to take part!
SPANSULE capsules: Each SPANSULE sustained-release capsule is so prepared that an initial dose is released promptly and the remaining medication is released gradually over a prolonged period. Each capsule, with brown cap and clear body, contains dextroamphetamine sulfate. The 5-mg capsule is imprinted 5 mg and 3512 on the brown cap and is imprinted 5 mg and SB on the clear body. The 10-mg capsule is imprinted 10 mg--3513--on the brown cap and is imprinted 10 mg--SB--on the clear body. The 15-mg capsule is imprinted 15 mg and 3514 on the brown cap and is imprinted 15 mg and SB on the clear body. A narrow bar appears above and below 15 mg and 3514. Product reformulation in 1996 has caused a minor change in the color of the time-released pellets within each capsule. Inactive ingredients now consist of cetyl alcohol, D&C Yellow No. 10, dibutyl sebacate, ethylcellulose, FD&C Blue No. 1, FD&C Blue No. 1 aluminum lake, FD&C Red No. 40, FD&C Yellow No. 6, gelatin, hypromellose, propylene glycol, povidone, silicon dioxide, sodium lauryl sulfate, sugar spheres, and trace amounts of other inactive ingredients. Tablets: Each triangular, orange, scored tablet is debossed SKF and E19 and contains dextroamphetamine sulfate, 5 mg. Inactive ingredients consist of calcium sulfate, FD&C Yellow No. 5 tartrazine ; , FD&C Yellow No. 6, gelatin, lactose, mineral oil, starch, stearic acid, sucrose, talc, and trace amounts of other inactive ingredients and allegra.
The infant's diet. Therefore, the timing of the newborn screening sample collection will have no effect on the reliability of this test. However, because GALT analysis is performed using red blood cells, there may be a falsenegative result for up to 3 months if the infant has received a blood transfusion. Tests for galactose and galactose 1-phosphate depend on the infant's diet; therefore, it is important to be sure that the infant is receiving galactose-containing formula or breast milk before testing. MS MS can be used as a technology in screening for galactosemia.93 Follow-up and Diagnostic Testing All newborn infants with positive screening results should be evaluated rapidly by an experienced physician for feeding difficulty, signs of sepsis, jaundice, and hepatomegaly. Untreated classic galactosemia may progress very rapidly to hepatic toxicity, with death resulting from sepsis or bleeding. Immediate restriction of dietary galactose is critical and should not await diagnostic testing. Galactose restriction should be instituted immediately even in the asymptomatic child and should be continued until the extent of enzyme deficiency, if any, is known. Diagnostic studies for classic galactosemia include quantitative analysis of GALT and red blood cell galactose 1-phosphate. In states where the screening test measures GALT activity, these studies will establish or rule out classic galactosemia. When the screening results, including estimates of galactose and galactose 1-phosphate and quantitative GALT activity, are normal, quantitative analysis of GALK and GALE are required to identify these forms of galactosemia. It is likely that another pathway exists that can be responsible for galactose disposal, but this pathway has not been characterized.94 Brief Overview of Disease Management Infants suspected of having galactosemia should be fed with a galactose-free formula until diagnostic testing confirms a specific diagnosis. Children who are seriously ill at the time of diagnosis of classic galactosemia require supportive care, which may include vitamin K supplementation and fresh-frozen plasma transfusions, antibiotics for presumed Gram-negative sepsis, and phototherapy for hyperbilirubinemia. After dietary galactose has been eliminated, most infants improve rapidly. Milk and milk products are excluded from the diet indefinitely, because significant ingestion of galactose at any age can be toxic.92 Because medications may contain galactose, the pediatrician should instruct parents to ask the pharmacist if a medication is galactose free before administering it to the child. Regular nutritional evaluation is necessary to ensure adequate calcium intake. Regular developmental evaluation and early speech assessment are also required. Girls should be monitored frequently. Equine infectious anaemia virus EIAV ; -based lentiviral can transduce CNS neurones Mazarakis et al., 2001 ; . Our study compares the pattern and efficacy of transduction in the dorsal root ganglion DRG ; by EIAV vectors pseudotyped with either the rabies-G glycoprotein rabies-G ; or vesicular stomatitis virus glycoprotein VSV-G ; , following different routes of administration. Adult male Wistar rats and C57BL 6 mice were anaesthetized with Medetomidine 0.25 and 0.5 mg kg, respectively, i.p. ; and ketamine 60 and 75 mg kg, respectively, i.p. ; . With sterile precautions an EIAV vector expressing -galactosidase titre 4-8 x 108 T.U. ml ; was infused slowly via a micropipette into the spinal cord, DRG, sciatic nerve or footpad. Animals were anaesthetized and perfused with 4 % paraformaldehyde at various times later. Expression of -galactosidase was determined by incubating 20 m cryostat tissue sections with either X-gal staining solution 1 mg ml X-gal in 0.1 M phosphate buffer containing 1.3 mM MgCl2, 3 mM K3Fe CN ; 6, 3 mM K4Fe CN ; 6 ; overnight at 37C or rabbit anti--galactosidase 1: 300, Europa Labs ; followed by Alexa Fluor 488 1: 1000, Molecular Probes ; . Intraspinal injections 2 l rat and 1 l mouse ; of both VSV-G and rabies-G EIAV vectors produced abundant transduction within the cord at 3 and 5 weeks respectively n 3 ; Figure A ; . The rabies-G vector also transduced approximately 40 % of DRG neurons in the treated segment compared to 5 % using the VSV-G vector Figure B ; . Roughly equal numbers of NF200, CGRP and IB4 positive cells were transduced in DRG. Direct DRG injection 2 x 0.5 l ; or peripheral sciatic nerve or footpad injections 6-10 l ; n 3 each, 4 week survival ; transduced fewer DRG neurones but by all routes transduction was better using rabies-G pseudotyped EIAV vector. This study demonstrates that the pattern and efficacy of neuronal transduction in the DRG is dependent on the pseudotype of the lentiviral vector as well as the route of injection. For retrograde expression of the EIAV vector in the DRG the rabies-G EIAV vector was more efficient while expression at the site of injection was more effective using the VSV-G pseudotyped EIAV vector. These pseudotyped lentiviral vectors can be used to manipulate experimentally gene expression of sensory neurones in the DRG and allopurinol.

Actos benefits

Quinoline yellow CI47005 E104 ; * sunset yellow FCF CI15985 E110 ; * indigo carmine CI73015 E132 ; . Akamin 100 capsules Each Akamin 100 capsule contains 100 mg of minocycline. The capsules also contain: * lactose * maize starch * magnesium stearate * titanium dioxide CI77891 E171 ; * iron oxide black CI77499 E172 ; * sodium lauryl sulfate * colloidal anhydrous silica * potable water * gelatin * shellac * propylene glycol * ammonium hydroxide * potassium hydroxide. Akamin tablets and capsules are gluten free. Side effects also any side that is using to take or may drugs not that affect your and includes minerals doctors and alphagan.
If you already have this problem, you should avoid actos.

PI Date Code: Feb 2007 Legal category: POM. MARKETING AUTHORISATION HOLDER: Takeda Global R & D Centre Europe ; Ltd. Arundel Great Court, 2 Arundel Street, London, WC2R 3DA, United Kingdom. Acos is a registered trademark owned by Takeda Pharmaceutical Company Ltd. For further information contact: Takeda UK Ltd. Takeda House, Mercury Park, Wycombe Lane, Wooburn Green, High Wycombe, Bucks AC070222 HP10 0HH. Tel: 01628-537900, Fax: 01628-526617 and alprazolam.
Troglitazone was available only briefly before being withdrawn because it caused serious liver damage. In clinical trials with troglitazone, some cases of elevated liver enzymes and drug-associated hepatitis occurred. However, it was only once the drug was more widely used that the extent of the problem became apparent. Many cases of acute liver failure, some of which were fatal, were reported leading to the drug's withdrawal in March 2000.9 The experience with troglitazone led to heightened awareness of the potential for liver toxicity with pioglitazone Actls ; and rosiglitazone Avandia ; . Liver function tests are recommended for patients taking pioglitazone or rosiglitazone at baseline, every 2 months for the first 12 months, then periodically thereafter.10, 11 Postmarketing surveillance has so far not revealed a similarly widespread problem with pioglitazone and rosiglitazone. However, some cases of liver problems have been reported with both drugs.12. Earl R. Parson, M.D. Chief Medical Officer Boston MEPS and altace and actos, because actso and heart failure. Home articles health topics diseases & conditions tests & procedures drugs & supplements symptoms site map quick links diabetes symptoms of diabetes diabetic diet type 1 diabetes type 2 diabetes diabetes treatment diabetes recipes diabetes research byetta metformin januvia adtos avandia diabetes insipidus avandia avandia is prescribed to treat type 2 diabetes by helping to improve insulin sensitivity and by helping to lower blood sugar and keep it under better control.
Actos and avandia study
Can epsolin be used as 1st line drug in such cases and amaryl. Uses of ctos pioglitazone is an anti-diabetic drug such as thiazolidinedione-type, also known as glitazones and used along with a proper diet and exercise program to control high blood sugar in patients with type 2 diabetes.
Plane F, Holland M, Waldron GJ, Garland CJ, Boyle JP. Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries. Br J Pharmacol 1997; 121 8 ; : 1509-11. Randall MD, Kendall DA. Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation. Eur J Pharmacol 1997; 335 2-3 ; : 205-9. See, G. 1890. Anwendung der Cannabis indica in der Behandlung der Neurosen und gastrischen Dyspepsieen. Dtsch Med Wschr 60 31-34 ; : 679-682, 727-730, 748-754, Siegling A, Hofmann HA, Denzer D, Mauler F, De Vry J. Cannabinoid CB 1 ; receptor upregulation in a rat model of chronic neuropathic pain. Eur J Pharmacol 2001; 415 1 ; : R5-R7 Simoneau II, Hamza MS, Mata HP, Siegel EM, Vanderah TW, Porreca F, Makriyannis A, Malan TP Jr. The cannabinoid agonist WIN55, 212-2 suppresses opioid-induced emesis in ferrets. Anesthesiology 2001; 94 5 ; : 882-7. Stamer WD, Golightly SF, Hosohata Y, Ryan EP, Porter AC, Varga E, Noecker RJ, Felder CC, Yamamura HI. Cannabinoid CB 1 ; receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues. Eur J Pharmacol 2001; 431 3 ; : 277-86. Tyler K, Hillard CJ, Greenwood-Van Meerveld B. Inhibition of small intestinal secretion by cannabinoids is CB1 receptor-mediated in rats. Eur J Pharmacol 2000; 409 2 ; : 207-11. van der Stelt M, Veldhuis WB, van Haaften GW, Fezza F, Bisogno T, Bar PR, Veldink GA, Vliegenthart JF, Di Marzo V, Nicolay K. Exogenous anandamide protects rat brain against acute neuronal injury in vivo. J Neurosci 2001; 21 22 ; : 8765-71. Van Sickle MD, Oland LD, Ho W, Hillard CJ, Mackie K, Davison JS, Sharkey KA. Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret. Gastroenterology 2001; 121 4 ; : 767-74. Walker JM, Huang SM, Strangman NM, Tsou K, Sanudo-Pena MC. Pain modulation by release of the endogenous cannabinoid anandamide. Proc Natl Acad Sci U S A 1999; 96 21 ; : 12198-203. Williams CM, Kirkham TC. Observational analysis of feeding induced by Delta 9 ; -THC and anandamide. Physiol Behav 2002; 76 2 ; : 241-50.

Actos 30mg tablets
RLS can be a serious disorder, but it is treatable. If you suspect that you may have RLS, consult a qualified healthcare provider. Literature distributed by the Restless Legs Syndrome Foundation, including this brochure, is offered for information purposes only, and should not be considered a substitute for the advice of a healthcare provider. The Restless Legs Syndrome Foundation does not advertise, endorse, or sponsor any products or services.
Biostim has been shown to be a strong inhibitor of 5-alpha reductase in the dermal papilla and to increase hair cell proliferation, particularly on hairs suppressed by androgenic activity, for instance, actos 15mg. Median 17.6 months ; survival for the paclitaxel-treated limited disease cohort is comparable to this and other SWOG trials as well as to the control arm of the recently reported Intergroup 0096 study [19, 20]. Recent studies most notably the Intergroup 0096 study ; have excluded patients with pleural effusions from the category of limited disease. In addition, others have excluded patients with a performance status of 2 from entry. As these factors have been previously evaluated by SWOG and found to be of considerable prognostic importance, we performed an exploratory analysis of patients with pleural effusion n 15 ; or performance status of 2 n both [21]. Surprisingly, there were no differences in terms of median, progression-free, or overall survival. This is most likely the result of small numbers of patients in each of these subsets. When the total S9713 population was divided into prognostic groups as previously defined by SWOG--patients younger than 70 years of age, had normal lactose dehydrogenase, and no pleural effusion versus those with any of those features--no significant difference in survival was found [21]. Again, this was most likely as a result of the small numbers of patients evaluated. Future and adalat.
2. "NIHCM Misuses FDA's Priority Review Classification System." As stated in the report, the FDA's priority and standard designations are robust criteria for distinguishing drugs that make clinical improvements from those that are similar to those already on the market. The CDER uses four specific criteria for determining whether a new drug may receive a priority review. New drugs may qualify by: 1 ; evidence of increased effectiveness in the treatment, prevention, or diagnosis of disease; 2 ; elimination or substantial reduction of a treatment-limiting drug reaction; 3 ; documented evidence of improved patient compliance; or 4 ; evidence of safety or effectiveness for a new patient population. They need not treat a serious or life-threatening disease to qualify, as do biologics products reviewed by CBER see page 6 and footnote 10 in the report ; . CDER gives the coveted priority designation to any drug that can show an advantage in one of the four ways mentioned above. Thus, as the report states on page 6, both Vioxx and Celebrex received priority reviews because they were believed to have less severe and prevalent gastrointestinal side effects than common non-steroidal anti-inflammatory NSAID ; drugs such as ibuprofen and naproxen. Gastrointestinal problems occur for only a small percentage of patients receiving NSAID drugs, which are safe enough to be sold over-the-counter. Nevertheless, the FDA viewed the small increase in safety as sufficient to warrant a priority designation. CDER also gives a priority review to "me too" drugs if they can demonstrate improvement over a breakthrough drug that is already on the market. For example, the FDA gave priority reviews to both Avandia and Actos, two anti-diabetic drugs approved in 1999 for treatment of type 2 diabetes. Avandia and Qctos were "me too" drugs using the same mechanism of action as Rezulin, which was already on the market at the time of their approval. However, they appeared to be safer than Rezulin, which raised concerns because of liver toxicity and was later withdrawn from the market. Thus, drugs receive a standard review only if they fail to demonstrate a clinical advantage in any of the four accepted ways. The FDA's priority or standard designation at the time of review does not, of course, constitute final judgment on the value of the drug. A medicine's full range of benefits and side effects and interactions with other medicines are usually not known until the drug has entered the market and been used by thousands of patients. Thus: Some medications prove effective for new indications after they have entered the market. New indications approved under efficacy supplement applications have emerged as an important source of priority rated new technology, as the NIHCM Foundation study notes in Appendix 2 on pages 20-21. On the other hand, some drugs eventually manifest side effects and interactions that were not known at the time of approval, and must be withdrawn from the market for safety reasons. In recent years the FDA has removed several medications approved since the mid-1990s, including four standard NMEs and two priority NMEs that were included in the report's count of total NMEs. 3.

Clasificacion de los actos juridicos

Microscope light, nutritionist gainesville florida, retinoschisis in women, lumbar muscle strain and alpha blocker wikipedia. Granuloma annulare kids, lyme disease washington state, connective tissue autoimmune and creatine fat loss or kegel exercises biofeedback.

Actos administrativos de admision

Actos 15mg pioglitazone, actos escolares 20 de junio, actos benefits, actos and avandia study and actos 30mg tablets. Clasificacion de los actos juridicos, actos administrativos de admision, actos medicine purpose and actos tzd or actos fatty liver.

© 2005-2008 Mer.freevar.com, Inc. All rights reserved.